US News and World Report - "T Cells Take On Cancer" - Linda Childers

New York, NY
 – October 23, 2017  –– 

When cancer patients first meet Joshua Brody, MD, assistant professor of medicine, hematology and medical oncology and director of the lymphoma immunotherapy program at the Icahn School of Medicine at Mount Sinai, one of the first things they ask for is “the Jimmy Carter cure.” For those diagnosed with an advanced cancer, former President Carter’s story is nothing short of a bombshell. “Immunotherapy is one of the greatest advances in cancer treatment in the last 40 years,” said Dr. Brody. The push is on to take full advantage. When treatment works, the results are often dramatic, with remissions lasting years in people who otherwise would have had weeks or months to live. “I have one patient with stage 4 bladder cancer, and through the use of combined immunotherapies, he has no detectable signs of cancer,” said Matthew Galsky, MD, associate professor of medicine, hematology, and medical oncology and director of genitourinary medical oncology at The Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai.

-Joshua Brody, MD, Assistant Professor, Medicine, Hematology and Medical Oncology, Director, Lymphoma Immunotherapy Program, Icahn School of Medicine at Mount Sinai 

- Matthew Galsky, MD, Associate Professor, Medicine, Hematology and Medical Oncology; Assistant Professor, Urology; Director, Genitourinary Medical Oncology, The Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai

Learn more